Test Story

By: NewsUSA

March 27, 2025 at 20:00 PM EDT

(NewsUSA) - For more details, including important safety information, on VenaSeal, visit: https://www.medtronic.com/breakfree.

Sources

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi: 10.1016/j.jvs.2011.01.079.

Mayo Clinic: Varicose Veinshttps://www.mayoclinic.org/diseases-conditions/varicose-veins/symptoms-causes/syc-20350643

National Heart Lung and Blood Institute: Varicose Veins https://www.nhlbi.nih.gov/health/varicose-veins

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994. doi: 10.1016/j.jvs.2014.11.071.

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. doi: 10.1016/j.jvsv.2020.05.019.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658–666. doi: 10.1016/j.jvsv.2017.03.016.

Symbol	Price	Change (%)
AMZN	231.78	+0.00 (0.00%)
AAPL	278.78	+0.00 (0.00%)
AMD	221.42	+0.00 (0.00%)
BAC	54.08	+0.00 (0.00%)
GOOG	320.83	-0.17 (-0.05%)
META	650.13	+0.00 (0.00%)
MSFT	478.56	+0.00 (0.00%)
NVDA	183.78	+0.00 (0.00%)
ORCL	223.01	+0.00 (0.00%)
TSLA	451.45	+0.00 (0.00%)

Symbol

Price

Change (%)

AMZN

231.78

+0.00 (0.00%)

AAPL

278.78

+0.00 (0.00%)

AMD

221.42

+0.00 (0.00%)

BAC

54.08

+0.00 (0.00%)

GOOG

320.83

-0.17 (-0.05%)

Test Story

More News

Recent Quotes